Viroj Wiwanitkit
Wiwanitkit House, Bangkhae, Bangkok, Thailand In reply: We would like to thank professor Wiwanitkit for his interest in our recent publication 'HE4, CA-125, and cystic ovarian mass'. It is important to emphasize that our report concerns the use of HE4 and CA-125 as a tool when a pelvic mass or cyst already has been found and the question of referral or not to a specialized gynecologic-oncology surgical unit has to be answered. In our study the use of Risk of Malignancy Algorithm (ROMA) was also evaluated. Our study is however not focusing on screening of the general population and subsequently symptom index was not used. Nevertheless we agree that a thorough economical analyze of cost and evaluation of possible patient morbidity should be performed before implementation into clinical practice.
CONFLICT OF INTEREST
No potential conflict of interest relevant to this article was reported.
